Mike Kleppinger

About Mike Kleppinger

A highly accomplished Senior Management Executive with demonstrated success leading strategy, innovation, operational execution, and growth for global life science and biopharmaceutical companies. Unique expertise in clinical research, patient & site recruitment, commercialization of pharmaceuticals, and brand equity expansion. Key member of senior corporate leadership teams. Consistently drive revenue, improve profitability, expand market share, and exceed shareholder returns by developing and implementing strong operational process, quality initiatives, environmental improvements, growth initiatives, marketing campaigns, consultative selling strategies via actionable addressable market intelligence, introducing new offerings, improving customer satisfaction, forming strategic partnerships, and penetrating new niche markets.CAREER HIGHLIGHTS Growth Leadership: Drive performance-based global growth for major organizations. Developed long-range plan to generate more than $4B in new business for Syneos Health (SYNH). Led strategic planning for Quintiles to secure over $2B in new revenue, sustain above-market growth targets, and expanded Curia beyond the $1B revenue threshold. Product/Services Rationalization/Commercialization: Initiates strategies to branded products and services to grow volume, market share, and leverage distribution. Led customer engagement during rapid formulation development, scale up, and regulatory approval of multiple COVID vaccines at Curia Global. Strategic Marketing & Brand Equity Expansion: Utilizes direct\\indirect channels to optimize market coverage while controlling costs and managing risk. Transform end-to-end strategy by re-branding disparate acquisitions into a One Curia culture and “Idea to Impact” market tagline. Process Development: Build sustainable, repeatable, and scalable end-to-end processes and back-office infrastructure to streamline operations and drive performance. Develop corporate communications and go-to-market plans to enhance customer journey engagement. Team Building & Leadership: Building high-performance teams out of disparate groups, and integrating diverse teams and functions into deployable assets. Invests in team training and talent development to create a common vernacular for global teams across multiple cultures and geographies. M&A Integration & Restructuring: Re-branded AMRI into Curia Global and consolidated multiple disparate business units into two. Led IPO of SYNH and commercial integrations of inVentiv into SYNH & Novella into Quintiles.

Experience

1. President, Commercial Operations Clinical Research Group

   Thermo Fisher Scientific

   Jan 2024 — Present · Wilmington, NC, US

   Leads a group of 750+ employees across Commercial, Marketing, Sales, and Business Development, supporting $5B in annual revenue creation. Directly accountable for delivering business through executive oversight of the entire commercial organization, leading strategy planning, and execution of client-centric innovative solutions to maximize client satisfaction and proactive engagement to drive forward operational models.• Spearheads deep strategic and tactical development and strategy execution.• Drives continued business growth and organization success while expanding market access and share.• Develops cross-functional partnerships, enhances organizational talent, and leads vision and organizational transformation.

Education

• Campbell University

  Master of Business Administration - MBA

• North Carolina Wesleyan University

  Bachelor's degree, Business Administration and Management, General

• Capella University

  Doctor of Philosophy - PhD, Business, Management, Marketing, and Related Support Services